{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Exact Sciences Corporation"},"Symbol":{"label":"Symbol","value":"EXAS"},"Address":{"label":"Address","value":"5505 ENDEAVOR LANE, MADISON, Wisconsin, 53719, United States"},"Phone":{"label":"Phone","value":"+1 608 284-5700"},"Industry":{"label":"Industry","value":"Medical Specialities"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Exact Sciences Corporation, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test, a non-invasive stool-based DNA test, is a pre-cancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a genetic-based treatment selection test for breast, prostate, and colon cancers. With the acquisitions of Base Genomics and Thrive Earlier Detection, Exact is building a multi-cancer early screening test to detect over 14 cancers, a test that would be one of earliest entrants in multi-cancer liquid biopsy cancer screening."},"CompanyUrl":{"label":"Company Url","value":"https://www.exactsciences.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Frederick Baehner","title":"Co-Chief Medical Officer & Precision Oncology"},{"name":"Jorge A. Garces","title":"Chief Science Officer"},{"name":"Kevin T. Conroy","title":"Chairman, President & Chief Executive Officer"},{"name":"Nassar Nizami","title":"Chief Information Officer"},{"name":"Paul J. Limburg","title":"Co-Chief Medical Officer & Screening"},{"name":"Tomasz M. Beer","title":"Co-Chief Medical Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}